Ramritu Prabha, Halton Kate, Cook David, Whitby Michael, Graves Nicholas
The Centre for Healthcare Related Infection Surveillance & Prevention, Princess Alexandra Hospital, Brisbane, Qld, Australia.
J Adv Nurs. 2008 Apr;62(1):3-21. doi: 10.1111/j.1365-2648.2007.04564.x.
This paper is a report of a systematic review and meta-analysis of strategies, other than antimicrobial coated catheters, hypothesized to reduce risk of catheter-related bloodstream infections and catheter colonization in the intensive care unit setting.
Catheter-related bloodstream infections occur at a rate of 5 per 1000 catheter days in the intensive care unit setting and cause substantial mortality and excess cost. Reducing risk of catheter-related bloodstream infections among intensive care unit patients will save costs, reduce length of stay, and improve outcomes.
A systematic review of studies published between January 1985 and February 2007 was carried out using the keywords 'catheterization - central venous' with combinations of infection*, prevention* and bloodstream*. All included studies were screened by two reviewers, a validated data extraction instrument was used and data collection was completed by two blinded independent reviewers. Risk ratios for catheter-related bloodstream infections and catheter colonization were estimated with 95% confidence intervals for each study. Results from studies of similar interventions were pooled using meta-analyses.
Twenty-three studies were included in the review. The strategies that reduced catheter colonization included insertion of central venous catheters in the subclavian vein rather than other sites, use of alternate skin disinfection solutions before catheter insertion and use of Vitacuff in combination with polymyxin, neomycin and bacitracin ointment. Strategies to reduce catheter-related bloodstream infection included staff education multifaceted infection control programmes and performance feedback.
A range of interventions may reduce risks of catheter-related bloodstream infection, in addition to antimicrobial catheters.
本文是一项系统评价和荟萃分析的报告,内容是关于在重症监护病房环境中,除抗菌涂层导管外,其他被认为可降低导管相关血流感染和导管定植风险的策略。
在重症监护病房环境中,导管相关血流感染的发生率为每1000个导管日发生5例,会导致大量死亡和额外费用。降低重症监护病房患者导管相关血流感染的风险将节省成本、缩短住院时间并改善治疗结果。
使用关键词“导管插入术 - 中心静脉”与“感染*”“预防*”和“血流*”的组合,对1985年1月至2007年2月发表的研究进行系统评价。所有纳入研究由两名评审员进行筛选,使用经过验证的数据提取工具,并由两名独立的盲法评审员完成数据收集。对每项研究估计导管相关血流感染和导管定植的风险比及95%置信区间。对类似干预措施的研究结果进行荟萃分析汇总。
该评价纳入了23项研究。降低导管定植的策略包括在锁骨下静脉而非其他部位插入中心静脉导管、在导管插入前使用替代皮肤消毒溶液以及将Vitacuff与多粘菌素、新霉素和杆菌肽软膏联合使用。降低导管相关血流感染的策略包括工作人员教育、多方面感染控制计划和绩效反馈。
除抗菌导管外,一系列干预措施可能降低导管相关血流感染的风险。